209
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Diversion of Benzodiazepines Through Healthcare Sources

, , &
Pages 48-56 | Published online: 28 Feb 2013
 

Abstract

Benzodiazepines (BZ) are often diverted from legal sources to illicit markets at various points in the distribution process beginning with a pharmaceutical manufacturer, followed by healthcare providers, and finally, to the intended users. Little is known about the extent of BZ diversion involving distribution points directly related to healthcare sources versus points further down the distribution chain. The present study examines the scope of BZ diversion, and the association between BZ dependence and the direct utilization of particular healthcare-related diversion sources among a diverse sample of prescription drug abusers in South Florida. Cross-sectional data were collected from five different groups of drug users: methadone-maintenance clients (n = 247), street drug users (n = 238), public-pay treatment clients (n = 245), private-pay treatment clients (n = 228), and stimulant-using men who have sex with men (MSM; n = 249). Findings suggest that those who are ages 26 to 35 years old, non-Hispanic White participants, private-pay treatment clients, those who are insured, and those with higher incomes had higher odds of utilizing healthcare diversion sources. Those who reported BZ dependence had 2.5 times greater odds of using a healthcare source to obtain BZs than those who did not meet criteria for dependence.

Acknowledgments

This research study was supported by a grant from the National Institute on Drug Abuse (NIDA; Grant # R01 DA021330). NIDA had no further role in the study design, the collection, analysis and interpretation of data, the writing of the report, or in the decision to submit the paper for publication. Furthermore, the views expressed in this article are those of the authors and do not necessarily reflect the position of the Department of Veterans Affairs or the United States government. We wish to acknowledge the original Principal Investigator, Dr. James A. Inciardi.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.